Acute phase reactant proteins.
Cooper
E H
EH
University of Leeds School of Medicine, United Kingdom.
D000209:Acute-Phase Proteins / Q000032:analysis*; D014408:Biomarkers, Tumor / Q000032:analysis*; D002272:Carcinoembryonic Antigen / Q000032:analysis; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000097:blood; D006023:Glycoproteins / Q000032:analysis; D006258:Head and Neck Neoplasms / Q000097:blood; D006801:Humans; D007249:Inflammation; D008175:Lung Neoplasms / Q000097:blood; D008297:Male; D009362:Neoplasm Metastasis; D009363:Neoplasm Proteins / Q000032:analysis*; D009369:Neoplasms / Q000737:chemistry*; D011379:Prognosis; D012307:Risk Factors; D000685:Serum Amyloid A Protein / Q000032:analysis; D014565:Urogenital Neoplasms / Q000097:blood
D000209:Acute-Phase Proteins; D014408:Biomarkers, Tumor; D002272:Carcinoembryonic Antigen; D006023:Glycoproteins; D009363:Neoplasm Proteins; D000685:Serum Amyloid A Protein